Bruker (BRKR) FY2013 results: revenue $1.8 billion, up 2.7% on the year
Bruker Corp. (BRKR) reported revenue of $1.8 billion for fiscal 2013, the year ended 31 December 2013, up 2.7% on the year before. Net income was $80 million, up 3.4%, and diluted earnings per share $0.48. The figures are the company's own, from the 10-K it filed with the SEC on 27 February 2014.
Revenue
$1.8 billion
+2.7% on the year
FY2009FY2013
Operating margin
8.1%
8.7% a year earlier
FY2009FY2013
Net income
$80 million
+3.4% on the year
FY2009FY2013
Diluted EPS
$0.48
+4.3% on the year
FY2009FY2013
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2013
FY2012
FY2011
On the year
Last 8 years
Revenue
1,839
1,791
1,652
+2.7%
Cost of revenue
1,034
962
899
+7.5%
Gross profit
805
829
752
-2.9%
Gross margin
43.8%
46.3%
45.6%
Research and development
190
195
177
-2.5%
Selling, general and administrative
438
440
407
-0.6%
Operating income
148
156
156
-5.0%
Operating margin
8.1%
8.7%
9.4%
Interest expense
13.4
14.3
7.3
-6.3%
Pre-tax income
125
138
146
-9.9%
Income tax
42.8
60.1
51.5
-28.8%
Effective tax rate
34.3%
43.5%
35.4%
Net income
80.1
77.5
92.3
+3.4%
Net margin
4.4%
4.3%
5.6%
Diluted EPS
$0.48
$0.46
$0.55
+4.3%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2013
FY2012
FY2011
On the year
Last 8 years
Operating cash flow
145
133
87.7
+8.9%
Capital expenditure
50.3
72.8
61.6
-30.9%
Free cash flow
94.7
60.3
26.1
+57.0%
Free cash flow margin
5.1%
3.4%
1.6%
Depreciation and amortisation
61.3
59.1
52.9
+3.7%
Share-based compensation
6.6
7.8
7.9
-15.4%
Diluted shares, weighted
168m
167m
167m
+0.7%
Shares outstanding at period end
168m
167m
166m
+0.6%
Balance sheet
$ million
FY2013
FY2012
FY2011
On the year
Last 8 years
Shareholders' equity
846
707
622
+19.7%
Non-controlling interest
4.1
3.1
3.4
+32.3%
Debt
355
337
303
+5.3%
Other liabilities
783
810
782
-3.3%
Total liabilities and equity
1,988
1,856
1,710
+7.1%
Fixed assets
300
284
249
+5.6%
Goodwill
127
116
100
+9.9%
Intangible assets
106
117
136
-9.7%
Cash and equivalents
439
311
246
+41.2%
Receivables
308
289
283
+6.3%
Inventory
590
612
576
-3.5%
Other assets
120
128
120
-6.8%
Total assets
1,988
1,856
1,710
+7.1%
10-K for the year ended 31 December 2013, filed 27 February 2014: the filing.